Commentary: Perioperative systemic therapy in early-stage non-small cell lung cancer: The future is bright

J Thorac Cardiovasc Surg. 2023 Feb;165(2):500-501. doi: 10.1016/j.jtcvs.2022.03.011. Epub 2022 Mar 24.

Authors

Alexis P Chidi¹, Stephen R Broderick²

Affiliations

¹ Division of Thoracic Surgery, Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Md.
² Division of Thoracic Surgery, Department of Surgery, The Johns Hopkins Medical Institutions, Baltimore, Md. Electronic address: sbroder7@jhmi.edu.

PMID: 35422324
DOI: 10.1016/j.jtcvs.2022.03.011

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung* / drug therapy
Carcinoma, Non-Small-Cell Lung* / pathology
Carcinoma, Non-Small-Cell Lung* / surgery
Forecasting
Humans
Lung Neoplasms* / pathology
Neoplasm Staging
Small Cell Lung Carcinoma*